Financials Autonomix Medical, Inc.
Equities
AMIX
US05330T1060
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.5 USD | -0.79% | -13.49% | 0.00% |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2022 | 2023 |
---|---|---|
Net sales | - | - |
EBITDA | - | - |
EBIT 1 | -13.59 | -1.99 |
Operating Margin | - | - |
Earnings before Tax (EBT) 1 | -13.33 | -1.99 |
Net income 1 | -13.33 | -1.99 |
Net margin | - | - |
EPS 2 | -6.197 | -0.1656 |
Free Cash Flow | - | -1.108 |
FCF margin | - | - |
FCF Conversion (EBITDA) | - | - |
FCF Conversion (Net income) | - | - |
Dividend per Share | - | - |
Announcement Date | 07/07/23 | 07/07/23 |
Balance Sheet Analysis
Fiscal Period: March | 2022 | 2023 |
---|---|---|
Net Debt 1 | - | - |
Net Cash position 1 | 2.04 | 0.86 |
Leverage (Debt/EBITDA) | - | - |
Free Cash Flow | - | -1.11 |
ROE (net income / shareholders' equity) | - | -153% |
ROA (Net income/ Total Assets) | - | -85.3% |
Assets 1 | - | 2.334 |
Book Value Per Share 2 | 0.9500 | 0.0500 |
Cash Flow per Share 2 | 0.9900 | 0.0700 |
Capex | - | - |
Capex / Sales | - | - |
Announcement Date | 07/07/23 | 07/07/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
0.00% | 47.03M | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+1.14% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- AMIX Stock
- Financials Autonomix Medical, Inc.